Androgen action on renal calcium and phosphate handling: Effects of bisphosphonate treatment and low calcium diet.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
20 08 2020
Historique:
received: 14 02 2020
revised: 05 05 2020
accepted: 03 06 2020
pubmed: 14 6 2020
medline: 3 6 2021
entrez: 14 6 2020
Statut: ppublish

Résumé

Renal calcium and phosphate handling is an important contributor to mineral homeostasis and bone health and the androgen receptor (AR) is highly expressed in the kidney. We investigated the short term effects of androgen deprivation on renal calcium and phosphate reabsorption, independent of their effects on bone. Two weeks following orchidectomy (ORX) of adult mice, bone loss occurred along with hypercalciuria, which was similarly prevented by testosterone and dihydrotestosterone supplementation. Treatment with bisphosphonates prior to ORX also inhibited hypercalciuria, indicating that the calcium flux originated from the bone. Renal calcium and phosphate transporter expression was increased post-ORX, independent of bisphosphonates. Furthermore, androgen deprivation appeared to stimulate local synthesis of 1,25(OH)

Identifiants

pubmed: 32533994
pii: S0303-7207(20)30191-X
doi: 10.1016/j.mce.2020.110891
pii:
doi:

Substances chimiques

Androgens 0
Calcium, Dietary 0
Diphosphonates 0
Phosphates 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110891

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Rougin Khalil (R)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Ioannis Simitsidellis (I)

Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, United Kingdom.

Na Ri Kim (NR)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Ferran Jardi (F)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Dieter Schollaert (D)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Ludo Deboel (L)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Philippa Saunders (P)

Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, United Kingdom.

Geert Carmeliet (G)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Frank Claessens (F)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Belgium.

Dirk Vanderschueren (D)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium.

Brigitte Decallonne (B)

Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Aging, KU Leuven, Belgium. Electronic address: brigitte.decallonne@kuleuven.be.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH